Opening Plenary Session

Session Leader(s):

• Niranjan S. Kulkarni, PhD, Senior Director, Consulting Services | Associate, CRB

Speaker(s):

• Thomas B. Hartman, President and CEO, ISPE
• Joanne R. Barrick, RPh, Sr. Director TS/MS Validation, Eli Lilly and Company
• Robin Kumoluyi, VP & Chief Quality Officer, Janssen Pharmaceuticals Johnson & Johnson Corporation
• Lou W. Kennedy, CEO and Owner, Nephron Pharmaceuticals
• Elizabeth Miller, Pharm.D., Assistant Commissioner for Medical Products and Tobacco Operations, FDA/ORA
• Deusdedit Mubangizi, Unit Head Prequalification Unit (PQT) Regulation & Prequalification Department, World Health Organization
• Kristen M. Farrell, CI/CT, Vice President, Cure SMA NE Chapter